Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers

Precipio

14/11/2025 21:39

Overview

Precipio Q3 2025 revenue grows 30% YoY to $6.8 mln

Adjusted EBITDA turns positive in Q3 2025, improving by over $500K from Q2

Company generates $285K cash from operations in Q3 2025

Outlook

Company anticipates gross margins to increase towards 50%

Result Drivers

PATHOLOGY SERVICES GROWTH - Revenue increased 20% due to new customer accounts in the pipeline

PRODUCT DIVISION EXPANSION - Revenue rose 16% from existing customers and new panel orders

OPERATIONAL EFFICIENCIES - Positive EBITDA and cash generation attributed to operational efficiencies and financial discipline

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$6.80 mln


Press Release: ID:nGNX4zwyxv

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)